India, Aug. 26 -- Bengaluru-based Canarys has announced the launch of Auryis, their artificial intelligence (AI)-powered, unified compliance assessment platform purpose-built for Pharma and Life Sciences. This marks a pivotal step in Canarys' evolution-from a services-led organisation to a product-led company.

In a fast-changing regulatory landscape, Auryis delivers real-time, structured, and audit-ready compliance insights across all digital content-including SOPs, clinical trial documents, training materials, and marketing assets. It intelligently maps each element to external regulations (GxP, FDA, EMA), internal standards, and custom business rules-helping organisations anticipate and mitigate non-compliance risk before it escalates....